| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |